Many pharmacovigilance (PV) professionals still think AI is limited to search or summarization. But in reality, AI can support every step of the AE literature monitoring workflow. Here’s how it works in our IPV system: 1️⃣ Document Retrieval Given a…
Several years ago, our team developed iSearch, a product from a project aiming to develop a deep learning–powered search engine for biomedical literature. You can still access it today at biokde.insilicom.com. At that time, we were thrilled by the results.…
We recently put this to the test. In a pilot study, our team compared Insilicom’s IPV platform with traditional Boolean keyword searches for detecting adverse events (AEs). We focused on three well-known post-market drugs: 💊 Nivolumab, Dupilumab, and Semaglutide. ________________________________________…
Over the years, quite a few people have asked me about my experience applying for SBIR/STTR grants. Since I’ve learned many lessons through trial and error, and after winning 6 SBIR/STTR awards since my first NSF STTR grant in 2014,…
A few years ago, everyone was talking about Generative AI as if it would change everything overnight.Now? It’s sliding down the trough of disillusionment.People are realizing how hard it is to control hallucinations, especially when accuracy matters, like in biomedical…
